Vidula Vachharajani, MD
Staff
Location:
Cleveland Clinic Main Campus
Research
The Vidula Vachharajani lab investigates immuno-metabolic response in sepsis and septic shock with specific interest in the role of sirtuin nutrient sensors.
Biography
Education & Professional Highlights
Education & FellowshipsFellowship - LSU Health Shreveport
Critical Care Medicine
Shreveport, LA USA
2004
Fellowship - LSU Health Shreveport
Critical Care Medicine
Shreveport, LA USA
2004
Residency - Louisiana State University Health Sciences Center-Shreveport
Internal Medicine
SHreveport, LA USA
2000
Residency - Princess Alexandra Hospital
Internal Medicine
Harlow Essex, UK United Kingdom
1997
Fellowship - Bombay University
Critical Care
Mumbai, India
1992
Fellowship - Bombay Hospital
Critical Care
Mumbai, MS,
1992
Fellowship - Sir H.N. Hospital
Critical Care
Mumbai, India
1991
Residency - Grant Medical College, University of Bombay
Respiratory Medicine
Bombay, India, MD USA
1990
Medical Education - Grant Medical College
Mumbai, India
1986
- Internal Medicine - Critical Care Medicine
Research
The Vachharajani lab investigates immuno-metabolic response in sepsis and septic shock with specific interest in the role of sirtuin nutrient sensors. The team focuses on immuno-metabolic pathways that dysregulate host response to pathogen during early and late phases of sepsis, with the goal of developing effective therapies to reduce immune dysfunction and sepsis-related mortality.
The current NIH-funded projects using human biospecimen and laboratory models of sepsis, focus on the effect of high fat diet and alcohol consumption on the immune response in sepsis and septic shock.
Our Team
Selected Publications
View publications for Vidula Vachharajani, MD
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Careers
Research News
Dr. Vachharajani and her team will study the immuno-metabolic mechanisms that trigger dysfunction in alcohol consumption with sepsis to identify new therapeutic targets for expanded treatments.